Price target $6
https://www.benzinga.com/news/21/02/19723114/jefferies-initiates-coverage-on-vistagen-therapeutics-with-buy-rating-announces-price-target-of-6
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.